You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Carcinoids

Showing 1 - 25 of 31
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Chromogranin A as Blood Marker in Cancer Patients

Completed
  • Gastric Neoplasms
  • +3 more
  • BRAHMS CgA II KRYPTOR
  • Palo Alto, California
  • +3 more
Dec 19, 2022

Carcinoid Tumor Lung, Neuroendocrine Tumor of the Lung, Carcinoma, Small-Cell Lung Trial in Iowa City (212-Lead Pentixather,

Not yet recruiting
  • Carcinoid Tumor Lung
  • +2 more
  • 212-Lead Pentixather
  • 203-Lead Pentixather SPECT/CT
  • Iowa City, Iowa
    The University of Iowa Theranostics Center
Sep 23, 2022

Zollinger-Ellison Syndrome Trial (YF476)

Terminated
Has Results
  • Zollinger-Ellison Syndrome
  • (no location specified)
Jan 28, 2021

Neuroendocrine Tumors Trial in Milan (Lanreotide and Metformin)

Active, not recruiting
  • Neuroendocrine Tumors
  • Lanreotide and Metformin
  • Milan, Italy
    NationalCIMilan
Jun 4, 2021

Carcinoid Syndrome, Carcinoid Tumor, Digestive System Neuroendocrine Tumor G1 Trial in Houston (Dual-Energy Computed Tomography)

Recruiting
  • Carcinoid Syndrome
  • +3 more
  • Dual-Energy Computed Tomography
  • Houston, Texas
    M D Anderson Cancer Center
Jul 28, 2021

Chronic Atrophic Gastritis, Hypergastrinaemia, Type I Gastric Carcinoids Trial in Liverpool (YF476)

Completed
  • Chronic Atrophic Gastritis
  • +2 more
  • Liverpool, United Kingdom
    Royal Liverpool University Hospital
Aug 14, 2019

Routine Transcervical Thymectomy in MEN-1 Patients

Completed
  • Multiple Endocrine Neoplasia Type 1 (MEN-1)
  • Thymic Carcinoid
  • Routine thymectomy, which has been performed
  • Singapore, Singapore
    National University Hospital
Sep 25, 2021

Advanced Carcinoid Tumor, Digestive System Neuroendocrine Tumor, Multiple Endocrine Neoplasia Type 1 Trial in Houston

Recruiting
  • Advanced Carcinoid Tumor
  • +4 more
  • Houston, Texas
    M D Anderson Cancer Center
Sep 22, 2022

Lung Cancer, Neuroendocrine Tumor Trial in Beijing (68Ga-NOTA-3P-TATE-RGD)

Recruiting
  • Lung Cancer
  • Neuroendocrine Neoplasm
  • Beijing, Beijing, China
    Peking Union Medical College Hospitall, Chinese Academy of Medic
Mar 30, 2022

Dihydropyrimidine Induced Gastrointestinal Toxicity in Colorectal Cancer Trial in Uppsala (Salovum and SPC-flakes active or )

Recruiting
  • Dihydropyrimidine Induced Gastrointestinal Toxicity in Colorectal Cancer
  • Salovum and SPC-flakes active or placebo
  • Uppsala, Sweden
    University hospital
May 18, 2022

Neuroendocrine Tumors, Lung Neuroendocrine Tumor, Thymus Tumors Trial in France, Italy, Spain (177Lu-edotreotide, Everolimus)

Not yet recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Bourdeaux, France
  • +24 more
Jun 23, 2023

Gastroenteropancreatico Tumors, Neuroendocrine Tumors, Neuroendocrine Tumors Trial run by the National Cancer Institute (NCI)

Recruiting
  • Gastroenteropancreatico Tumors
  • +2 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Pheochromocytoma, Paraganglioma, Neuroendocrine Tumors Trial run by the NCI (Lu-177-DOTATATE, Ga-68-DOTATATE, F-18-FDG)

Recruiting
  • Pheochromocytoma
  • +3 more
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
Jan 19, 2023

Neuroendocrine Cancer Trial in United States (Carfilzomib)

Completed
Has Results
  • Neuroendocrine Cancer
  • Denver, Colorado
  • +9 more
Jun 7, 2022

Neuroendocrine Tumors Trial in Porto Alegre (99m Tc - HYNIC -TOC EDDA and 111In - DTPA-octreotide)

Completed
  • Neuroendocrine Tumors
  • 99m Tc - HYNIC -TOC EDDA and 111In - DTPA-octreotide
  • Porto Alegre, Rio Grande Do Sul, Brazil
    Instituto do Cérebro do Rio Grande do Sul
Oct 1, 2020

Neuroendocrine Tumors Trial in Warszawa (90Y-DOTATATE, (177Lu-DOTAOTyr3)Octreotate, 90Y DOTATATE and 177Lu DOTATATE (mix each of

Unknown status
  • Neuroendocrine Tumors
  • Warszawa, Poland
    Centrum Diagnostyczno-Lecznicze Gammed
Mar 31, 2020

Models in Neuroendocrine Neoplasm

Recruiting
  • Neuroendocrine Neoplasm
  • Biopsy, open or laparoscopic surgery
  • Shanghai, Shanghai, China
    Department of Pancreatic Surgery, Fudan University Shanghai Canc
Sep 19, 2021

Metastatic Colorectal Cancer Trial in Milan (Capecitabine, Temozolomide, Irinotecan)

Completed
  • Metastatic Colorectal Cancer
  • Milan, Mi, Italy
    Fondazione IRCCS Istituto Nazionale Tumori
Sep 3, 2021

Carcinoid Cancer, Neuroendocrine Tumors, Medullary Thyroid Cancer Trial in Los Angeles (68Ga DOTATATE)

No longer available
  • Carcinoid Cancer
  • +3 more
  • 68Ga DOTATATE
  • Los Angeles, California
    UCLA Hospital
Jul 23, 2020

Neuroendocrine Tumors Trial in France (Oxaliplatin-based chemo, Alkylating-based chemo)

Active, not recruiting
  • Neuroendocrine Tumors
  • Oxaliplatin-based chemotherapy
  • Alkylating-based chemotherapy
  • Amiens, France
  • +18 more
Mar 15, 2022

Pituitary Tumours Trial in Göteborg (Gallium-68 DOTATOC PET)

Terminated
  • Pituitary Tumours
  • Gallium-68 DOTATOC PET
  • Göteborg, Sweden
    Center of Endocrinology and Metabolism, Sahlgrenska university H
Mar 15, 2022

Advanced and Metastatic Silent Neuro-Endocrine Tumors, Carcinoma, Neuroendocrine Trial in Worldwide (Everolimus)

Completed
Has Results
  • Advanced and Metastatic Silent Neuro-Endocrine Tumors
  • +6 more
  • Bordeaux, France
  • +39 more
Aug 14, 2018

Neuroendocrine Tumours Trial in Italy (Lanreotide (Autogel formulation) and Temozolomide)

Completed
Has Results
  • Neuroendocrine Tumours
  • Lanreotide (Autogel formulation) and Temozolomide
  • Viagrande, Catania, Italy
  • +9 more
Sep 9, 2020

Overall Survival of Large Cell Neuroendocrine Lung Cancer

Completed
  • Survival Outcomes of Patients With Pulmonary LCNEC
    • (no location specified)
    Jun 27, 2019

    Recurrence Rates of Type I Gastric Neuroendocrine Tumors Treated

    Unknown status
    • Gastric NET
    • Beijing, Beijing, China
      Peking Union Medical College Hospital
    Jan 20, 2019